{"pmid": "12749708", "sentences": {"sent_1": {"Section": "", "text": "Between May 1999 and December 2001 , 18 patients with supratentorial glioblastoma were treated with boronophenylalanine ( BPA ) - based BNCT within a context of a prospective clinical trial ( protocol P - 01 ) .", "entities": {"entity_1": {"text": "supratentorial glioblastoma", "class": "Participant", "negation": 0, "UMLS": "C0017636:glioblastoma,", "index": 1, "start": 10}, "entity_2": {"text": "boronophenylalanine ( BPA )", "class": "Intervention", "negation": 0, "UMLS": "C0048114:4-boronophenylalanine,", "index": 2, "start": 15}, "entity_3": {"text": "BNCT", "class": "Intervention", "negation": 0, "UMLS": "", "index": 3, "start": 21}}, "relations": {}}, "sent_2": {"Section": "", "text": "All patients underwent prior surgery , but none had received conventional radiotherapy or cancer chemotherapy before BNCT .", "entities": {"entity_4": {"text": "prior surgery", "class": "Participant", "negation": 0, "UMLS": "C0543467:surgery,", "index": 1, "start": 3}, "entity_5": {"text": "conventional radiotherapy", "class": "Intervention", "negation": 0, "UMLS": "C0034619:radiotherapy,", "index": 2, "start": 10}, "entity_6": {"text": "cancer chemotherapy before BNCT", "class": "Participant", "negation": 0, "UMLS": "C0392920:cancer chemotherapy,", "index": 3, "start": 13}}, "relations": {}}, "sent_3": {"Section": "", "text": "BPA - fructose was given as 2 - h infusion atBPA - dosages ranging from 290 to 400 mg / kg prior to neutron beam irradiation , which was given as a single fraction from two fields .", "entities": {"entity_7": {"text": "BPA - fructose", "class": "Outcome", "negation": 0, "UMLS": "C0016745:fructose,", "index": 1, "start": 0}, "attribute_1": {"text": "290 to 400 mg / kg", "class": "measure", "negation": 0, "UMLS": "", "index": 2, "start": 15}, "entity_8": {"text": "neutron beam irradiation", "class": "Intervention", "negation": 0, "UMLS": "C1522449:irradiation,", "index": 3, "start": 23}}, "relations": {}}}}